Editor of Patient Care Online.
Screening and Treatment for Osteoporosis Lacking for Persons with Cirrhosis, According to Real-World Analysis
Less than a quarter of persons with cirrhosis who are diagnosed with osteoporosis are started on treatment, reported researchers.
Daily Dose: High BMI in Adolescence Linked to CKD in Young Adulthood
Your daily dose of the clinical news you may have missed.
ACG Releases New Clinical Guideline for Management of Alcohol-Associated Liver Disease
The new guideline underscores the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with ALD.
Semaglutide Linked to Lower Risk of Suicidal Ideation in Patients with Obesity, Type 2 Diabetes
Semaglutide was associated with a lower risk of first-time and recurrent suicidal ideations in patients with obesity or overweight or T2D, according to new study.
Obesity Management: What Clinicians Need to Know in 2024
Angela Fitch, MD, president of the Obesity Medicine Association, details what to look forward to this year in terms of obesity management.
Colorectal Cancer Incidence Has Increased Among Younger Men, Not Women, According to Recent Study
Data from recent Austrian study suggest that sex should be considered when determining screening age for colorectal cancer, reported authors.
Daily Dose: Higher Omega-3 Fatty Acid Intake May Slow Pulmonary Fibrosis Disease Progression
Advancements in Obesity Medicine in 2023: Breakthroughs and Shifting Perspectives on Treatment
President of the Obesity Medicine Association discusses how clinician perspectives on obesity and obesity treatment are changing for the better.
Frequent Addition of Salt to Food Linked to Higher Risk of Chronic Kidney Disease
Adults who said they always added extra salt to their food had an 11% higher risk for developing CKD compared with those who never or only rarely added salt, according to new research.
High BMI in Adolescence Linked to Early CKD in Young Adulthood, Shows New Research
Findings underscore the importance of preventive measures and management of risk factors associated with CKD in adolescents with elevated BMI, report researchers.
Daily Dose: US Childhood Vaccination Exemption Rate Unprecedented in 2022-23
Daily Dose: Menstrual Disorders Raise Risk for Future CVD in Young Women
Clinician Education on Obesity Has Not Caught Up to Disease State, Says OMA President
Angela Fitch, MD, discusses the importance of clinician education in addressing obesity with patients.
Addressing the Gap: Advocacy Groups Call for Inclusion of Patients with Obesity in Clinical Trials
President of the Obesity Medicine Association discusses a recent joint statement from the OMA and 4 other organizations calling for inclusion of patients with obesity in drug research.
Daily Dose: Impact of COVID-19 Pandemic on Parental Vaccine Hesitancy in the US
Daily Dose: USPSTF Recommends Behavioral Interventions for Children with Obesity
Daily Dose: Pregnancy-related ESKD Influences Access to Nephrology Care
Daily Dose: Treating the Gut Microbiome Shortens Long COVID
Key Developments in Obesity Medicine in 2023: An Expert Discussion
Angela Fitch, MD, president of the Obesity Medicine Association discusses key pharmaceutical and research developments in obesity medicine in 2023.
Daily Dose: Tirzepatide Discontinuation Results in Weight Regain
FDA Updates LDL-C Lowering Indication for Bempedoic Acid, Bempedoic Acid plus Ezetimibe Tablets
The US FDA approved expanded indications for bempedoic acid and bempedoic acid plus ezetimibe for primary hyperlipidemia.
Daily Dose: Omega-3 Fatty Acids Reduce CVD Risk in Individuals with Family History of CVD
Daily Dose: Nerivio Neuromodulation Device for Migraine
USPSTF Recommends Intensive, Behavioral Interventions for Children and Adolescents with Obesity
The task force recommends clinicians provide or refer children and adolescents with a high BMI to intensive, comprehensive behavioral interventions.
Daily Dose: Vegan Diet Linked to Better Cardiovascular Health
Tirzepatide Demonstrates Sustained Weight Loss but Discontinuation Results in Weight Regain: SURMOUNT-4 Trial
Study participants randomized to placebo for 1 year after 36 weeks on tirzepatide had mean weight regain of 14% vs augmented loss among those who continued on the medication.
Daily Dose: Eligible Adults Lack Statin Prevention for ASCVD
New Data Show Omega-3 Polyunsaturated Fatty Acids Lower CVD Risk in Persons with Family History of CVD
Higher intake of omega-3 polyunsaturated fatty acids may reduce the risk for cardiovascular disease in persons with a family history of CVD.
Daily Dose: Coadministration of RSV and Influenza Vaccines
High Prevalence of Husband, Wife Duos with Hypertension Observed Globally in New Study
The prevalence of concordant hypertension among middle-aged and older heterosexual couples in the US, UK, China, and India ranged from 20% go 47%, reported researchers.